Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1999
05/27/1999DE19751949A1 Neuronal regeneration and neurodegenerative disease treatment with aminomethyl-chroman derivatives
05/27/1999CA2310250A1 Treatment for alzheimer's disease
05/27/1999CA2310249A1 Treatment for alzheimer's disease
05/27/1999CA2310248A1 5-ht1f agonists
05/27/1999CA2310244A1 Pyranones, methods of preparing and using them
05/27/1999CA2309966A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999CA2309905A1 Isoquinoline derivatives and their therapeutical use
05/27/1999CA2309744A1 Use of mirtazapine for treating sleep apneas
05/27/1999CA2309392A1 Method for treating attention deficit disorder
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917535A1 Neuroactive peptide
05/26/1999EP0917530A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
05/26/1999EP0917463A2 Tramadol multiple unit formulations
05/26/1999EP0817769B1 Borneol esters, process for their preparation and their pharmaceutical use
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0777663B1 Use of substituted 6-amino-4h-pyrans
05/26/1999EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0516795B1 Medicaments containing a quisqualate receptor antagonist and a dopamine agonist for the treatment of parkinson's disease
05/26/1999CN1217720A Benzofuryl derivatives and their use
05/26/1999CN1217716A Crystal modified body of medicine
05/26/1999CN1217711A Aryl substituted cyclic amines as selective dopamine D3 ligands
05/26/1999CN1217327A D-proline derivative
05/25/1999US5906996 Tetramine treatment of neurological disorders
05/25/1999US5906988 Methods of treatment using ranolazine and related piperazine derivatives
05/25/1999US5906985 Treating neurodegenerative diseases, central nervous disorder and as antipsychotic, anticonvulsant, analgesic and antiemetic agents
05/25/1999US5906976 Method and composition for treating neuronal degeneration
05/25/1999CA2126611C Opiod formulations having extended controlled release
05/20/1999WO1999024836A1 125 human secreted proteins
05/20/1999WO1999024475A1 Piperazine-cyclodextrin complexes
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024451A2 Adenosine a1 receptor agonists
05/20/1999WO1999024450A2 Adensine a1 receptor agonists
05/20/1999WO1999024449A2 Adenosine a1 receptor agonists
05/20/1999WO1999024436A1 1'-[4-[1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro [isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides
05/20/1999WO1999024423A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999WO1999024422A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
05/20/1999WO1999024421A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
05/20/1999WO1999024420A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999WO1999024405A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024398A2 Urea derivatives and their use as integrin inhibitors
05/20/1999WO1999024394A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024064A1 Antigen specific to meniere's disease and medical use thereof
05/20/1999WO1999024058A2 Neuronal uses of bmp-11
05/20/1999WO1999024057A2 Neuronal uses of bmp-11
05/20/1999WO1999024043A1 Viscous compositions containing carbon dioxide
05/20/1999WO1999024033A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1999024026A2 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
05/20/1999WO1999023881A1 Composition and method for preventing or alleviating migraine headaches
05/20/1999WO1999016753A3 Tricyclic 3-oxo-propanenitrile compounds
05/20/1999WO1999015526A3 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
05/20/1999WO1999015191A3 Cytokines having neurotrophic activity
05/20/1999WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment
05/20/1999DE19750623A1 New 2H-1-pyran-2-one derivatives useful as anticonvulsants and neuroprotectants
05/20/1999CA2309923A1 Composition and method for preventing or alleviating migraine headaches
05/20/1999CA2309626A1 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
05/20/1999CA2309609A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
05/20/1999CA2309538A1 Neuronal uses of bone morphogenetic protein -11
05/20/1999CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999CA2309200A1 Adenosine a1 receptor agonists
05/20/1999CA2309199A1 Adensine a1 receptor agonists
05/20/1999CA2309177A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999CA2309162A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308768A1 125 human secreted proteins
05/20/1999CA2308716A1 Urea derivatives and their use as integrin inhibitors
05/20/1999CA2308586A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999CA2308269A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999CA2306477A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
05/20/1999CA2306465A1 Piperazine-cyclodextrin complexes
05/20/1999CA2276080A1 Antigen specific to meniere's disease and medical use thereof
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916673A1 6-Amino purine derivatives having PDE-IV inhibition activity
05/19/1999EP0916672A1 6-Amino purine derivatives having PDE-IV inhibition activity and intermediates
05/19/1999EP0916670A2 Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists
05/19/1999EP0916346A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
05/19/1999EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application
05/19/1999EP0915877A1 SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE
05/19/1999EP0915875A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
05/19/1999EP0915856A1 Diphenyl heterocycles as potassium channel modulators
05/19/1999EP0915855A1 Novel compounds with analgesic effect
05/19/1999EP0915850A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
05/19/1999EP0915848A1 1,2-diarylindole as cox-2 inhibitors
05/19/1999EP0915847A1 Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
05/19/1999EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses
1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 1833